TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
23 hedge funds and large institutions have $1.48M invested in TFF Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
38% more capital invested
Capital invested by funds: $1.07M → $1.48M (+$407K)
10% more funds holding
Funds holding: 21 → 23 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$83.3K |
| 2 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$48.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$26.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.2K |
| 5 |
Renaissance Technologies
New York
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.88K |
| 2 |
OP
ORG Partners
Roanoke,
Indiana
|
-$394 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$118 |
TFFP Hedge Fund Activity: Q3 2024 in Review
23 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q3 2024, worth a combined $1.48M — up 38% from $1.07M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TFFP positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, adding an estimated $83.3K. The largest seller was Tower Research Capital (TRC), cutting an estimated $5.88K.
- 23 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q3 2024, up from 21 in Q2 2024.
- Funds reported $1.48M of TFF Pharmaceuticals, Inc. Common Stock stock for Q3 2024, up 38% quarter-over-quarter.
- 3 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of +2 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q3 2024 was Armistice Capital, an estimated $83.3K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q3 2024 was Tower Research Capital (TRC), an estimated $5.88K sold.
Based on aggregated 13F filings for Q3 2024.